Back
Shengfeng Development Vs. Moderna Industry Stock Comparison
Sell
13
SFWL
Shengfeng Development
Last Price:
$1.04
Seasonality Move:
-14.16%
Sell
21
MRNA
Moderna
Last Price:
$42.42
Seasonality Move:
19.97%
Sell
13
Shengfeng Development (SFWL)
is a Sell
Is Shengfeng Development a Buy, Sell or Hold?
-
The current Shengfeng Development [SFWL] share price is $1.02. The Score for SFWL is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
SFWL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SFWL Stock Price Chart
What is Shengfeng Development's stock price today?
-
The Shengfeng Development share price today is $1.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SFWL is experiencing selling pressure, which indicates risk of future bearish movement.
MRNA Stock Price Chart
SFWL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 38.56 | Sell |
Chaikin Money Flow: | -32630 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.02 - 1.08) | Sell |
Bollinger Bands (100): | (1.1 - 1.34) | Sell |
MRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.84 | Sell |
Relative Strength Index (14 RSI): | 47.29 | Sell |
Chaikin Money Flow: | -293401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.28 - 42.88) | Sell |
Bollinger Bands (100): | (39.14 - 65.28) | Sell |
SFWL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.03 | Sell |
20-day SMA: | 1.05 | Sell |
50-day SMA: | 1.13 | Sell |
200-day SMA: | 1.35 | Sell |
8-day EMA: | 1.03 | Sell |
20-day EMA: | 1.05 | Sell |
50-day EMA: | 1.12 | Sell |
200-day EMA: | 1.82 | Sell |
MRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.11 | Buy |
20-day SMA: | 39.35 | Sell |
50-day SMA: | 40.91 | Sell |
200-day SMA: | 85.24 | Sell |
8-day EMA: | 36.96 | Buy |
20-day EMA: | 38.78 | Sell |
50-day EMA: | 43.4 | Sell |
200-day EMA: | 72.01 | Sell |
Shengfeng Development Earnings Growth & SFWL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Moderna Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $2.09 per share.
Shengfeng Development Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Moderna Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |